Investment
Northern Gritstone backs spin out of Imperagen, a University of Manchester Life Science Business
Imperagen has developed a unique technology to accelerate the design, optimisation, and validation of novel enzymes for large molecular drug discovery. Northern Gritstone, along with IQ Capital, has led a £3.5 million Seed Round to fund the initial spin out Read more…